Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-07-09
1994-01-11
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514114, 5142355, 514255, 514337, 514392, 514456, A61K 3135, A61K 3144, A61K 3166, A61K 31415, A61K 31495, A61K 31535
Patent
active
052781690
ABSTRACT:
A method for the treatment and prevention of fibrillation using one or more potassium channel activators. Also, disclosed is a process for the preparation of compounds of the formula ##STR1## and the tautomeric forms ##STR2## wherein R''and R" are as defined herein.
REFERENCES:
patent: 4057636 (1977-11-01), Petersen
Petersen et al., "Synthesis and Hypotensive Activity of N-Alkyl-N"-Cyano-N'-Pyridylguanidines", Journal of Medicinal Chemistry, 1978, vol. 21, No. 8.
E. T. Hansen & H. J. Petersen, "Synthesis of N-Alkyl-N-Cyano-4-Pyridylguanidines From 4-Pyridylthiocarbamic Acid via N-Alkyl-N'-4-Pyridylthioureas, or via 4-Pyridylcyaniminothiocarbamic Acid", Synthetic Comm., 14(13), 1275-1283 (1983).
P. Siegl et al., "Effects of ATP-Sensitive Potassium Channel Modulators Glyburide and BRL 34915 on Ischemia-Induced Fibrillation in Isolated Rat Hearts", FASEB Journal, vol. 3, A3607 (1989).
Nigel Cook, "The Pharmacology of Potassium Channels and their Therapeutic Potential", TIPS, vol. 9, pp. 21-28, (1988).
M. Bacaner et al., "Potassium Channel Blockade: A Mechanism for Suppressing Ventricular Fibrillation", Proc. Nat'l Acad. Sci., U.S.A., vol. 83, 2223-2227, Med. Sciences (1986).
M. J. Kerr et al., "Suppression of Ventricular Arrhythmias After Coronary Artery Ligation by Pinacidil, A Vasodilator Drug", J. Card. Pharm. vol. 7, 875-883 (1985).
T. C. Hamilton et al., Gen. Pharmac., vol. 20, No. 1, pp. 1-9 (1989).
G. Kotaro et al., Pharmacology, vol. 109, p. 49 (1988).
G. Scholtyaik, Pharmacology, vol. 107, p. 43 (1987).
R. D. Kempsford, Chemical Abstracts, vol. 111, pp. 44-45 (1989).
M. Iwaki, et al., Mammaliam Pathol. Biochem., vol. 106, p. 491 (1987).
S. Imanishi et al., Chemical Abstracts, vol. 101, p. 42 (1984).
B. Liu et al., Chemical Abstracts, vol. 110, p. 60, (1989).
J. C. Sheenan et al., J. of Organic Chemistry, vol. 26, pp. 2525-2528 (1981).
K. S. Atwal. et al., Tetrahedron Letters, vol. 30, No. 52, pp. 7313-7316 (1989).
Atwal Karnail
Grover Gary J.
E. R. Squibb & Sons Inc.
Friedman S. J.
Furman Jr. Theodore R.
LandOfFree
Method of treating or prevention of fibrillation of the heart does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating or prevention of fibrillation of the heart, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating or prevention of fibrillation of the heart will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1631542